Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) EBT (2017 - 2025)

Historic EBT for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to -$5.4 million.

  • Bioceres Crop Solutions' EBT rose 2812.29% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.8 million, marking a year-over-year decrease of 98792.36%. This contributed to the annual value of -$57.6 million for FY2025, which is 62018.19% down from last year.
  • Per Bioceres Crop Solutions' latest filing, its EBT stood at -$5.4 million for Q3 2025, which was up 2812.29% from -$41.2 million recorded in Q2 2025.
  • In the past 5 years, Bioceres Crop Solutions' EBT ranged from a high of $22.3 million in Q1 2023 and a low of -$41.2 million during Q2 2025
  • For the 5-year period, Bioceres Crop Solutions' EBT averaged around -$791266.9, with its median value being -$233808.0 (2021).
  • In the last 5 years, Bioceres Crop Solutions' EBT plummeted by 288405.06% in 2022 and then soared by 41946.47% in 2023.
  • Bioceres Crop Solutions' EBT (Quarter) stood at $5.3 million in 2021, then tumbled by 257.84% to -$8.4 million in 2022, then soared by 213.6% to $9.6 million in 2023, then tumbled by 95.76% to $406149.0 in 2024, then plummeted by 1421.0% to -$5.4 million in 2025.
  • Its EBT was -$5.4 million in Q3 2025, compared to -$41.2 million in Q2 2025 and -$5.6 million in Q1 2025.